Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders

Sponsor

Norwegian University of Science and Technology (Other)

Overall Status

Completed

CT.gov ID

NCT00247234

Collaborator

(none)

Enrollment

Location

Arms

124

Actual Duration (Months)

0.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study intends to compare the effectiveness of schema therapy with standard psychiatric outpatient care for patients with borderline or avoidant personality disorder.

Condition or Disease	Intervention/Treatment	Phase
Personality Disorder, Borderline Avoidant Personality Disorder	Behavioral: Schema Therapy Behavioral: standard care	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

90 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder

Actual Study Start Date :

Sep 1, 2004

Actual Primary Completion Date :

Jun 1, 2011

Actual Study Completion Date :

Jan 1, 2015

Arms and Interventions

Arm	Intervention/Treatment
Experimental: schema therapy	Behavioral: Schema Therapy group based schema therapy
Active Comparator: standard care standard psychiatric out-patient care	Behavioral: standard care standard psychiatric out-patient care

Arm

Intervention/Treatment

Experimental: schema therapy

Behavioral: Schema Therapy

group based schema therapy

Active Comparator: standard care

standard psychiatric out-patient care

Behavioral: standard care

standard psychiatric out-patient care

Outcome Measures

Primary Outcome Measures

quality of life [5 years]
Self-report measures
depression [5 years]
Self-report measures
anxiety [5 years]
Self-report measures
suicidal ideation [5 years]
Self-report measures

Secondary Outcome Measures

Use of psychotropic medication [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:

20 Years to 50 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Avoidant or Borderline personality disorders

Exclusion Criteria:

Do not speak Scandinavian languages
Antisocial personality disorder
Narcissistic personality disorder
Affective bipolar disorder I
Schizophrenia
Mental impairment/organic brain disorder
Substance dependence
Planned pregnancy
Serious somatic illness
Anorexia Nervosa

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	St. Olavs Hospital	Trondheim		Norway	7030

Sponsors and Collaborators

Norwegian University of Science and Technology

Investigators

Study Chair: Are Holen, M.D., Ph.D., Department of Neuroscience, NTNU - Faculty of Medicine, MTFS, NO-7489 Trondheim, Norway

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Norwegian University of Science and Technology

ClinicalTrials.gov Identifier:

NCT00247234

Other Study ID Numbers:

ursula.falkmer+AEA-stolav.no

First Posted:

Nov 1, 2005

Last Update Posted:

Sep 25, 2017

Last Verified:

Sep 1, 2017

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Disease

Personality Disorders

Borderline Personality Disorder

Study Results

No Results Posted as of Sep 25, 2017